Core Viewpoint - Acute liver injury (ALI) is a common liver disease associated with significant mortality risks and complications, with no effective drug treatments available except for liver transplantation [2][5] Group 1: Background and Importance - ALI can lead to acute liver failure and various complications, posing a major threat to human health [2] - The causes of ALI are diverse, including infections, alcohol consumption, drug reactions, exposure to chemical toxins, and autoimmune diseases [2] Group 2: Current Research and Findings - Recent studies indicate that ferroptosis plays a critical role in the pathogenesis of various liver diseases, characterized by elevated levels of bioactive iron (Fe2+) and reactive oxygen species (ROS) [2][5] - A new study published in Cell Biomaterials describes a piezoelectric-mediated nanoenzyme heterojunction (BTO@CeO2) that effectively reduces lipid peroxidation and inhibits ferroptosis, alleviating drug-induced acute liver injury [3][7] Group 3: Innovative Treatment Approach - The BTO@CeO2 heterojunction enhances antioxidant properties and effectively clears ROS through localized ultrasound stimulation, while also converting Fe2+ to Fe3+, thereby regulating iron homeostasis [5][7] - This innovative approach demonstrates a new paradigm for ultrasound-responsive treatment, showcasing the potential of piezoelectric-nanoenzyme synergistic precision therapy for metabolic diseases [7]